| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 1.000 | None | 0.969 | 1 | 0 | 1994 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 1.000 | None | 0.959 | 1 | 0 | 1990 | 2020 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.900 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.800 | None | 0.931 | 1 | 0 | 1990 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.984 | 3 | 0 | 1996 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.920 | 1 | 0 | 1985 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.700 | None | 0.987 | 1 | 0 | 1989 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 1985 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.600 | None | 0.977 | 1 | 0 | 1998 | 2019 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.984 | 1 | 0 | 1997 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.960 | 1 | 0 | 1991 | 2019 | ||||||||
|
cyclin dependent kinase 1 | 0.482 | 0.808 | 0.99 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 0.957 | 1 | 0 | 1999 | 2019 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
disease | 0.600 | None | 0.941 | 1 | 0 | 2002 | 2020 | ||||||||
|
protein tyrosine kinase 2 | 0.497 | 0.808 | 1.00 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2003 | 2020 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1992 | 2016 | ||||||||
|
S-phase kinase associated protein 2 | 0.492 | 0.808 | 0.96 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
hepcidin antimicrobial peptide | 0.433 | 0.846 | 8.2E-03 |
|
disease | 0.600 | None | 0.950 | 1 | 0 | 2005 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2001 | 2015 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1996 | 2018 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
microRNA 106b | 0.523 | 0.808 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2009 | 2020 | |||||||||
|
microRNA 93 | 0.507 | 0.808 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2015 | 2020 | |||||||||
|
microRNA 96 | 0.536 | 0.769 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2019 |